Annual revenue:
$7.02M+$137.00K(+1.99%)Summary
- As of today (July 4, 2025), CLDX annual revenue is $7.02 million, with the most recent change of +$137.00 thousand (+1.99%) on December 31, 2024.
- During the last 3 years, CLDX annual revenue has risen by +$2.37 million (+50.94%).
- CLDX annual revenue is now -85.00% below its all-time high of $46.79 million, reached on December 31, 2010.
Performance
CLDX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$695.00K-$480.00K(-40.85%)Summary
- As of today (July 4, 2025), CLDX quarterly revenue is $695.00 thousand, with the most recent change of -$480.00 thousand (-40.85%) on March 31, 2025.
- Over the past year, CLDX quarterly revenue has increased by +$539.00 thousand (+345.51%).
- CLDX quarterly revenue is now -98.16% below its all-time high of $37.72 million, reached on December 31, 2010.
Performance
CLDX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$7.56M+$539.00K(+7.68%)Summary
- As of today (July 4, 2025), CLDX TTM revenue is $7.56 million, with the most recent change of +$539.00 thousand (+7.68%) on March 31, 2025.
- Over the past year, CLDX TTM revenue has increased by +$1.49 million (+24.49%).
- CLDX TTM revenue is now -83.85% below its all-time high of $46.79 million, reached on December 31, 2010.
Performance
CLDX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CLDX Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +2.0% | +345.5% | +24.5% |
3 y3 years | +50.9% | +299.4% | +82.5% |
5 y5 years | +96.5% | -74.5% | +71.9% |
CLDX Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +197.8% | -83.2% | +345.5% | -24.2% | +817.4% |
5 y | 5-year | -5.4% | +197.8% | -83.2% | +354.3% | -24.2% | +817.4% |
alltime | all time | -85.0% | +6920.0% | -98.2% | +119.0% | -83.8% | +383.8% |
CLDX Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $695.00K(-40.9%) | $7.56M(+7.7%) |
Dec 2024 | $7.02M(+2.0%) | $1.18M(-63.2%) | $7.02M(-29.6%) |
Sep 2024 | - | $3.19M(+27.7%) | $9.98M(+20.2%) |
Jun 2024 | - | $2.50M(+1501.3%) | $8.30M(+36.7%) |
Mar 2024 | - | $156.00K(-96.2%) | $6.07M(-11.8%) |
Dec 2023 | $6.88M(+192.0%) | $4.13M(+172.3%) | $6.88M(+57.7%) |
Sep 2023 | - | $1.52M(+466.0%) | $4.37M(+34.1%) |
Jun 2023 | - | $268.00K(-72.3%) | $3.25M(+3.3%) |
Mar 2023 | - | $967.00K(-40.0%) | $3.15M(+33.6%) |
Dec 2022 | $2.36M(-49.3%) | $1.61M(+296.3%) | $2.36M(+118.6%) |
Sep 2022 | - | $407.00K(+149.7%) | $1.08M(+30.8%) |
Jun 2022 | - | $163.00K(-6.3%) | $824.00K(-80.1%) |
Mar 2022 | - | $174.00K(-47.9%) | $4.14M(-11.0%) |
Dec 2021 | $4.65M(-37.3%) | $334.00K(+118.3%) | $4.65M(-42.6%) |
Sep 2021 | - | $153.00K(-95.6%) | $8.10M(-6.0%) |
Jun 2021 | - | $3.48M(+408.0%) | $8.62M(+60.4%) |
Mar 2021 | - | $685.00K(-81.9%) | $5.37M(-27.5%) |
Dec 2020 | $7.42M(+107.6%) | $3.79M(+466.6%) | $7.42M(+64.1%) |
Sep 2020 | - | $668.00K(+183.1%) | $4.52M(+2.8%) |
Jun 2020 | - | $236.00K(-91.3%) | $4.40M(-9.8%) |
Mar 2020 | - | $2.73M(+207.6%) | $4.88M(+36.5%) |
Dec 2019 | $3.57M(-62.5%) | $887.00K(+62.5%) | $3.57M(-19.7%) |
Sep 2019 | - | $546.00K(-23.6%) | $4.45M(-8.2%) |
Jun 2019 | - | $715.00K(-49.8%) | $4.84M(-29.7%) |
Mar 2019 | - | $1.43M(-19.2%) | $6.89M(-27.7%) |
Dec 2018 | $9.54M(-25.2%) | $1.76M(+87.5%) | $9.54M(-15.1%) |
Sep 2018 | - | $941.00K(-65.9%) | $11.23M(-21.0%) |
Jun 2018 | - | $2.76M(-32.1%) | $14.21M(-7.0%) |
Mar 2018 | - | $4.07M(+17.7%) | $15.28M(+19.9%) |
Dec 2017 | $12.74M(+87.8%) | $3.46M(-11.9%) | $12.74M(+14.2%) |
Sep 2017 | - | $3.92M(+2.5%) | $11.16M(+18.0%) |
Jun 2017 | - | $3.83M(+149.6%) | $9.46M(+34.8%) |
Mar 2017 | - | $1.53M(-18.1%) | $7.02M(+3.4%) |
Dec 2016 | $6.79M(+23.8%) | $1.87M(-15.6%) | $6.79M(+1.2%) |
Sep 2016 | - | $2.22M(+59.8%) | $6.70M(+21.7%) |
Jun 2016 | - | $1.39M(+6.6%) | $5.51M(-12.5%) |
Mar 2016 | - | $1.30M(-27.2%) | $6.30M(+14.9%) |
Dec 2015 | $5.48M(+52.8%) | $1.79M(+74.6%) | $5.48M(+6.1%) |
Sep 2015 | - | $1.03M(-52.9%) | $5.17M(-1.4%) |
Jun 2015 | - | $2.18M(+348.1%) | $5.24M(+43.4%) |
Mar 2015 | - | $486.00K(-67.1%) | $3.66M(+2.0%) |
Dec 2014 | $3.59M(-12.8%) | $1.48M(+34.2%) | $3.59M(+31.4%) |
Sep 2014 | - | $1.10M(+86.0%) | $2.73M(+4.6%) |
Jun 2014 | - | $592.00K(+42.3%) | $2.61M(+23.4%) |
Mar 2014 | - | $416.00K(-32.9%) | $2.11M(-48.6%) |
Dec 2013 | $4.11M(-63.3%) | $620.00K(-36.7%) | $4.11M(-42.4%) |
Sep 2013 | - | $980.00K(+910.3%) | $7.14M(-23.0%) |
Jun 2013 | - | $97.00K(-96.0%) | $9.27M(-17.1%) |
Mar 2013 | - | $2.41M(-33.8%) | $11.18M(-0.2%) |
Dec 2012 | $11.20M(+20.9%) | $3.65M(+17.2%) | $11.20M(+12.1%) |
Sep 2012 | - | $3.11M(+55.0%) | $9.99M(+8.1%) |
Jun 2012 | - | $2.01M(-17.4%) | $9.24M(+0.6%) |
Mar 2012 | - | $2.43M(-0.0%) | $9.18M(-0.9%) |
Dec 2011 | $9.27M(-80.2%) | $2.43M(+3.0%) | $9.27M(-79.2%) |
Sep 2011 | - | $2.36M(+21.1%) | $44.55M(-0.1%) |
Jun 2011 | - | $1.95M(-22.4%) | $44.60M(-2.2%) |
Mar 2011 | - | $2.52M(-93.3%) | $45.60M(-2.6%) |
Dec 2010 | $46.79M(+208.3%) | $37.72M(+1466.5%) | $46.79M(+239.0%) |
Sep 2010 | - | $2.41M(-18.4%) | $13.80M(-10.5%) |
Jun 2010 | - | $2.95M(-20.5%) | $15.43M(+1.8%) |
Mar 2010 | - | $3.71M(-21.6%) | $15.16M(-0.1%) |
Dec 2009 | $15.18M(+103.6%) | $4.73M(+17.4%) | $15.18M(+13.0%) |
Sep 2009 | - | $4.03M(+50.1%) | $13.44M(+14.2%) |
Jun 2009 | - | $2.69M(-28.1%) | $11.76M(+6.6%) |
Mar 2009 | - | $3.73M(+24.9%) | $11.04M(+48.1%) |
Dec 2008 | $7.46M(+430.4%) | $2.99M(+26.8%) | $7.46M(+53.7%) |
Sep 2008 | - | $2.36M(+20.2%) | $4.85M(+75.7%) |
Jun 2008 | - | $1.96M(+1230.8%) | $2.76M(+96.0%) |
Mar 2008 | - | $147.40K(-61.6%) | $1.41M(+0.2%) |
Dec 2007 | $1.41M(+56.3%) | $383.40K(+42.5%) | $1.41M(-153.5%) |
Sep 2007 | - | $269.00K(-55.8%) | -$2.63M(+2.7%) |
Jun 2007 | - | $609.20K(+323.1%) | -$2.56M(-3.9%) |
Mar 2007 | - | $144.00K(-103.9%) | -$2.66M(-396.2%) |
Dec 2006 | $899.20K(-70.9%) | -$3.65M(-1177.2%) | $899.20K(-82.7%) |
Sep 2006 | - | $339.00K(-32.9%) | $5.19M(-8.9%) |
Jun 2006 | - | $505.50K(-86.4%) | $5.69M(-2.3%) |
Mar 2006 | - | $3.71M(+484.3%) | $5.82M(+88.6%) |
Dec 2005 | $3.09M | $634.30K(-25.1%) | $3.09M(-38.1%) |
Sep 2005 | - | $846.30K(+32.8%) | $4.99M(+6.8%) |
Jun 2005 | - | $637.20K(-34.3%) | $4.67M(-5.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2005 | - | $970.60K(-61.7%) | $4.93M(-29.5%) |
Dec 2004 | $6.86M(+48.0%) | $2.54M(+380.9%) | $6.99M(+31.6%) |
Sep 2004 | - | $527.50K(-40.9%) | $5.31M(-21.9%) |
Jun 2004 | - | $893.00K(-70.5%) | $6.80M(-2.7%) |
Mar 2004 | - | $3.03M(+253.4%) | $6.98M(+50.7%) |
Dec 2003 | $4.63M(-30.9%) | $857.70K(-57.4%) | $4.63M(+1.0%) |
Sep 2003 | - | $2.02M(+86.9%) | $4.59M(-35.7%) |
Jun 2003 | - | $1.08M(+58.2%) | $7.13M(+6.5%) |
Mar 2003 | - | $681.70K(-15.9%) | $6.70M(-0.1%) |
Dec 2002 | $6.70M(+100.4%) | $810.80K(-82.2%) | $6.70M(-1.8%) |
Sep 2002 | - | $4.56M(+609.5%) | $6.83M(+128.0%) |
Jun 2002 | - | $642.80K(-7.0%) | $2.99M(-5.8%) |
Mar 2002 | - | $690.90K(-26.2%) | $3.18M(-5.0%) |
Dec 2001 | $3.35M(+338.4%) | $935.70K(+29.0%) | $3.35M(+23.4%) |
Sep 2001 | - | $725.50K(-12.1%) | $2.71M(+26.7%) |
Jun 2001 | - | $825.80K(-3.9%) | $2.14M(+45.8%) |
Mar 2001 | - | $859.00K(+184.8%) | $1.47M(+92.4%) |
Dec 2000 | $763.20K(-48.6%) | $301.60K(+96.0%) | $763.20K(+71.5%) |
Sep 2000 | - | $153.90K(0.0%) | $445.10K(-24.7%) |
Jun 2000 | - | $153.90K(+0.1%) | $591.20K(-54.0%) |
Mar 2000 | - | $153.80K(-1032.1%) | $1.29M(-10.2%) |
Dec 1999 | $1.48M(-31.0%) | -$16.50K(-105.5%) | $1.43M(-42.7%) |
Sep 1999 | - | $300.00K(-64.6%) | $2.50M(-3.8%) |
Jun 1999 | - | $847.90K(+182.6%) | $2.60M(+26.7%) |
Mar 1999 | - | $300.00K(-71.4%) | $2.05M(-4.7%) |
Dec 1998 | $2.15M(+80.4%) | $1.05M(+162.6%) | $2.15M(+44.1%) |
Sep 1998 | - | $400.00K(+33.3%) | $1.49M(+25.2%) |
Jun 1998 | - | $300.00K(-25.0%) | $1.19M(-25.1%) |
Mar 1998 | - | $400.00K(+2.0%) | $1.59M(+23.2%) |
Dec 1997 | $1.19M(+8.4%) | $392.10K(+292.1%) | $1.29M(+7.7%) |
Sep 1997 | - | $100.00K(-85.7%) | $1.20M(0.0%) |
Jun 1997 | - | $700.00K(+600.0%) | $1.20M(+71.4%) |
Mar 1997 | - | $100.00K(-66.7%) | $700.00K(-41.7%) |
Dec 1996 | $1.10M(-72.5%) | $300.00K(+200.0%) | $1.20M(-33.3%) |
Sep 1996 | - | $100.00K(-50.0%) | $1.80M(-28.0%) |
Jun 1996 | - | $200.00K(-66.7%) | $2.50M(-28.6%) |
Mar 1996 | - | $600.00K(-33.3%) | $3.50M(-14.6%) |
Dec 1995 | $4.00M(-42.9%) | $900.00K(+12.5%) | $4.10M(-2.4%) |
Sep 1995 | - | $800.00K(-33.3%) | $4.20M(-14.3%) |
Jun 1995 | - | $1.20M(0.0%) | $4.90M(-16.9%) |
Mar 1995 | - | $1.20M(+20.0%) | $5.90M(-15.7%) |
Dec 1994 | $7.00M(-22.2%) | $1.00M(-33.3%) | $7.00M(-14.6%) |
Sep 1994 | - | $1.50M(-31.8%) | $8.20M(-6.8%) |
Jun 1994 | - | $2.20M(-4.3%) | $8.80M(-4.3%) |
Mar 1994 | - | $2.30M(+4.5%) | $9.20M(+1.1%) |
Dec 1993 | $9.00M(+36.4%) | $2.20M(+4.8%) | $9.10M(+31.9%) |
Sep 1993 | - | $2.10M(-19.2%) | $6.90M(-10.4%) |
Jun 1993 | - | $2.60M(+18.2%) | $7.70M(+2.7%) |
Mar 1993 | - | $2.20M(-24.1%) | $7.50M(-30.6%) |
Dec 1992 | $6.60M(-25.8%) | - | - |
Oct 1992 | - | $2.90M(+20.8%) | $10.80M(+12.5%) |
Jul 1992 | - | $2.40M(0.0%) | $9.60M(+7.9%) |
Apr 1992 | - | $2.40M(-22.6%) | $8.90M(-1.1%) |
Apr 1992 | $8.90M(-12.7%) | - | - |
Jan 1992 | - | $3.10M(+82.4%) | $9.00M(+5.9%) |
Oct 1991 | - | $1.70M(0.0%) | $8.50M(-9.6%) |
Jul 1991 | - | $1.70M(-32.0%) | $9.40M(-7.8%) |
Apr 1991 | $10.20M(-6.4%) | $2.50M(-3.8%) | $10.20M(-8.1%) |
Jan 1991 | - | $2.60M(0.0%) | $11.10M(-7.5%) |
Oct 1990 | - | $2.60M(+4.0%) | $12.00M(+1.7%) |
Jul 1990 | - | $2.50M(-26.5%) | $11.80M(+3.5%) |
Apr 1990 | $10.90M(+39.7%) | $3.40M(-2.9%) | $11.40M(+10.7%) |
Jan 1990 | - | $3.50M(+45.8%) | $10.30M(+18.4%) |
Oct 1989 | - | $2.40M(+14.3%) | $8.70M(+6.1%) |
Jul 1989 | - | $2.10M(-8.7%) | $8.20M(+5.1%) |
Apr 1989 | $7.80M(+69.6%) | $2.30M(+21.1%) | $7.80M(+23.8%) |
Jan 1989 | - | $1.90M(0.0%) | $6.30M(+6.8%) |
Oct 1988 | - | $1.90M(+11.8%) | $5.90M(+13.5%) |
Jul 1988 | - | $1.70M(+112.5%) | $5.20M(+15.6%) |
Apr 1988 | $4.60M(+109.1%) | $800.00K(-46.7%) | $4.50M(+15.4%) |
Jan 1988 | - | $1.50M(+25.0%) | $3.90M(+21.9%) |
Oct 1987 | - | $1.20M(+20.0%) | $3.20M(+23.1%) |
Jul 1987 | - | $1.00M(+400.0%) | $2.60M(+44.4%) |
Apr 1987 | $2.20M(+2100.0%) | $200.00K(-75.0%) | $1.80M(+12.5%) |
Jan 1987 | - | $800.00K(+33.3%) | $1.60M(+77.8%) |
Oct 1986 | - | $600.00K(+200.0%) | $900.00K(+125.0%) |
Jul 1986 | - | $200.00K(+100.0%) | $400.00K(+33.3%) |
Apr 1986 | $100.00K | - | - |
Jan 1986 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
Oct 1985 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
Jul 1985 | - | $100.00K | $100.00K |
FAQ
- What is Celldex Therapeutics annual revenue?
- What is the all time high annual revenue for Celldex Therapeutics?
- What is Celldex Therapeutics annual revenue year-on-year change?
- What is Celldex Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly revenue year-on-year change?
- What is Celldex Therapeutics TTM revenue?
- What is the all time high TTM revenue for Celldex Therapeutics?
- What is Celldex Therapeutics TTM revenue year-on-year change?
What is Celldex Therapeutics annual revenue?
The current annual revenue of CLDX is $7.02M
What is the all time high annual revenue for Celldex Therapeutics?
Celldex Therapeutics all-time high annual revenue is $46.79M
What is Celldex Therapeutics annual revenue year-on-year change?
Over the past year, CLDX annual revenue has changed by +$137.00K (+1.99%)
What is Celldex Therapeutics quarterly revenue?
The current quarterly revenue of CLDX is $695.00K
What is the all time high quarterly revenue for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly revenue is $37.72M
What is Celldex Therapeutics quarterly revenue year-on-year change?
Over the past year, CLDX quarterly revenue has changed by +$539.00K (+345.51%)
What is Celldex Therapeutics TTM revenue?
The current TTM revenue of CLDX is $7.56M
What is the all time high TTM revenue for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM revenue is $46.79M
What is Celldex Therapeutics TTM revenue year-on-year change?
Over the past year, CLDX TTM revenue has changed by +$1.49M (+24.49%)